about
Neuromechanical principles underlying movement modularity and their implications for rehabilitationConcomitant pathologies among a spectrum of parkinsonian disordersBasal ganglia activity patterns in parkinsonism and computational modeling of their downstream effectsVascular parkinsonism--characteristics, pathogenesis and treatment.Automatic Classification on Multi-Modal MRI Data for Diagnosis of the Postural Instability and Gait Difficulty Subtype of Parkinson's Disease.Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study.Patterns of chronic venous insufficiency in the dural sinuses and extracranial draining veins and their relationship with white matter hyperintensities for patients with Parkinson's disease.White matter hyperintensities in Parkinson's disease: do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes?Von Willebrand factor inhibits mature smooth muscle gene expression through impairment of Notch signaling.Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.Age-related white matter changesProof of principle: Transformation approach alters caudate nucleus volume and structure-function associations.Increased CSF biomarkers of angiogenesis in Parkinson diseaseWhite matter characteristics of idiopathic normal pressure hydrocephalus: a diffusion tensor tract-based spatial statistic study.Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.Involvement of the optic nerve in mutated CSF1R-induced hereditary diffuse leukoencephalopathy with axonal spheroids.Association study of TREM2 polymorphism rs75932628 with leucoaraiosis or Parkinson's disease in the Han Chinese populationCerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's diseaseWhite matter microstructural integrity and executive function in Parkinson's diseaseCardiovascular physiology in premotor Parkinson's disease: a neuroepidemiologic studyDTI correlates of distinct cognitive impairments in Parkinson's diseaseUnusual idiopathic normal pressure hydrocephalus patient with marked asymmetric and upper body parkinsonismVerbal Memory in Parkinson's Disease: A Combined DTI and fMRI Study.Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre.White matter integrity and cognition in Parkinson's disease: a cross-sectional study.Influence of hypertension on neurocognitive domains in nondemented Parkinson's disease patients.Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutationsNeurobiology of cognitive impairment in Parkinson's disease.Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease?Oligodendroglia and neurotrophic factors in neurodegeneration.What can biomarkers tell us about cognition in Parkinson's disease?Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors.Neuroprotection by central nervous system remyelination: Molecular, cellular, and functional considerations.Aging of cerebral white matter.Frontal white matter injuries predestine gait difficulties in Parkinson's disease.Early Alzheimer's and Parkinson's disease pathology in urban children: Friend versus Foe responses--it is time to face the evidence.Sexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson's disease.Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage.Cognitive and MRI correlates of orthostatic hypotension in Parkinson's disease.
P2860
Q28088572-E72BC6DC-D9F7-4B60-BB8C-5E7E23CE615EQ28236077-792C470A-7CF3-4687-9F29-E39DDE52E023Q28271277-6E0DAD3A-93B2-4BB7-927C-B5AC66F93C51Q30940108-0DD5A2A6-8249-4E73-A24B-E55C6C20FBE7Q31095916-FC9BD423-68D9-4765-9D73-E48163DEBE64Q33729235-1D95B912-D013-4493-8418-76E8A90E1DA5Q34214673-0DD8F268-63FD-4301-9094-B1DAB73B3ADDQ34576193-CF84F3F5-3A70-4B0A-82A1-640ACC8B423AQ35005989-C64D8826-BE39-4111-87D7-B3E540E6D3E9Q35163173-42D84309-A487-450F-B673-67F67B4678E7Q35184834-6CCC9C5C-DAD2-436D-8358-97E02F2C00A2Q35634769-B1B0EFB6-09F7-438B-854F-96AB673CD2E8Q35825166-58CC3279-E026-493F-A4DA-DFA3F468041CQ35869318-323664FD-4F5F-4A06-A707-EBDE67CFF277Q35988441-02BF8820-574B-458B-B32A-CC347F9A64E9Q36130404-56E03148-9690-4B9A-9357-FA67B007B4EBQ36472325-0F27D45C-C05B-4461-ABDB-DA8426F0FBDCQ36718213-CCFA5509-7161-48D3-8E15-10A4ECD984B0Q36799758-5D10E285-2106-4B09-9007-2D918972B1AFQ36838860-9BB9EB7C-698A-4DC7-88EA-10F68A3FC514Q36875720-81F35B8F-E1EB-4190-9C37-453F2EE613CBQ36955609-E4055E38-FD51-492D-98B1-467AC776AAF0Q37053794-C6E5561D-6333-457E-833A-382B573BAC77Q37380546-1F0385CF-8889-4C8A-8069-963A2A08E5CEQ37517241-A57A0371-15C7-40C0-9481-F28BEA884C22Q37577056-C7861144-EA2F-43BC-BEEB-732FFF918EA4Q37687866-23192BC4-FFE8-4E4F-8713-C3613F5CE767Q38067143-2C34E16C-D5D9-40E2-AD2A-D44EC5E25684Q38085592-A1AFE34C-087E-44B8-8B77-228DC8F4A5FDQ38096248-D7B7B51F-8731-4781-B07F-A530EFF12DBFQ38206497-8940288F-FD03-415D-9008-4F3A357EA666Q38314584-1CA7DD2C-7C61-4DD4-9350-8D0D1914B98FQ38419501-E4EEB2E4-D075-4FD3-92F3-2740C1963CEEQ38952007-7394DC55-C508-4208-ABE7-970A0FE1373BQ39014387-71DD5FC2-B472-4470-924C-26904BC8AA90Q39552785-5FD7BB04-2113-4A46-8570-6C3C45A84E9CQ40099231-F1963675-678D-493B-93CD-3F4526119493Q41547487-2ED4C2F5-4CCE-40DF-BFF9-F09DF471C135Q42630995-0C19760D-614C-4B9C-A0DD-74209FCD3A22Q43981987-A5E57A38-2F0E-4CFA-83DF-BAA82AA616FD
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
White matter lesions in Parkinson disease.
@ast
White matter lesions in Parkinson disease.
@en
type
label
White matter lesions in Parkinson disease.
@ast
White matter lesions in Parkinson disease.
@en
prefLabel
White matter lesions in Parkinson disease.
@ast
White matter lesions in Parkinson disease.
@en
P2860
P356
P1476
White matter lesions in Parkinson disease.
@en
P2093
Roger L Albin
P2860
P2888
P304
P356
10.1038/NRNEUROL.2011.21
P407
P577
2011-02-22T00:00:00Z
P6179
1010778611